A drug underdevelopment may provide another pathway to lowering LDL levels.
Germin Fahim, PharmD., BCPS
Advertisement
Germin Fahim, Pharm.D., BCPS is Clinical Assistant Professor at Ernest Mario School of Pharmacy at Rutgers University ,and Clinical Pharmacist at Monmouth Medical Center in Long Branch, New Jersey.
Articles by Germin Fahim, PharmD., BCPS
Pharmacists must find good alternative therapeutic substitutions for sodium nitroprusside in the face of price gouging and drug shortages.
Reversal Agents for Direct-Acting Oral Anticoagulants
Cangrealor is the first FDA-approved P2Y12 inhibitor.
Advertisement
Latest Updated Articles
- Cardiac Matters
Published: March 15th 2017 | Updated:
- Cardiac Matters
Published: May 16th 2017 | Updated:
- BP Control in Cardiac Surgery: Nitroprusside Alternatives
Published: June 13th 2017 | Updated:
- Targeting LDL via PCSK-9 from a Different Pathway
Published: July 12th 2017 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Shifting from Reactive to Proactive Diabetes Counselors
2
Naloxone Sales Highlight Limited OTC Use, Access Challenges
3
Investigators Evaluate Decline in Percentage of Patients With COPD Using Inhaled Corticosteroids
4
Is it Safe for Birth Control Users to Go Years Without a Period?
5
